THE POWER OF VIBRANCE
BSE SENSEX
82,500.47
-689.81 -0.83%
11 Jul 25 | 16:00 | Close

Get Quote

Norris Medicines Ltd

1
(NORRIS | 524414 | INE744C01029 | SDD Non-Compliant| Details of Compliance Officer )
17.95 +0.25 (+1.41%)
EPS based on previous 4 trailing quarters in the scrip is zero | View More  
11 Jul 25 | 16:00 | All Prices in   


Previous Close 17.70
Open 18.00
High 18.00
Low 16.82
VWAP 17.40
52 Wk High 27.74
52 Wk Low 12.57
Upper Price Band 18.84
Lower Price Band 17.06
Price Band 5%
TTQ 1031
Turnover (Lakh) 0.18
2W Avg Qty` 1328
Mcap Full (Cr.) 17.95
Mcap FF (Cr.) 11.85
EPS (TTM) -1.24
CEPS (TTM) -0.70
PE/PB -14.48 / -1.25
ROE 8.62
Face Value 10.00
Category Listed
Group / Settlement Type X /T+1
Index -
Basic Industry Trading & Distributors
Corporate Governance

Corporate Governance : Quarter ending : March 2019
Quarter Ending :March 2019

Annexure I
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory NA
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO -
Sr Title (Mr/Ms) Name of the Director DIN Category Disqualification of Directors under section 164 of the Companies Act, 2013 Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of Appointment Date of Re-appointment Date of cessation Tenure of Director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity (Refer Regulation 17A(1) of Listing Regulations Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status
1 Mr Vimal Dhirendra Shah 01506655 Executive Director,Chairperson,MD - - - - - - - 01-04-2015 - - - 1 - 2 0 - - 0
2 Mr Sanjivkumar Shah 00534775 Non-Executive - Independent Director - - - - - - - 06-09-2014 - - 60.00 1 - 0 1 - - 0
3 Mr Hiten M Parikh 01686215 Non-Executive - Independent Director - - - - - - - 28-09-2015 - - 60.00 1 - 0 1 - - 0
4 Mr Shaik Amanullah Mohamed Azmathullah 06441691 Non-Executive - Independent Director - - - - - - - 29-09-2018 - - 60.00 1 - 2 0 - - 0
5 Mrs Jayanti Chandrasekar 01797568 Non-Executive - Independent Director - - - - - - - 29-09-2018 - - 60.00 1 - 0 0 - - 0
6 Mr Navnit Jethabhai Patel 01192209 Non-Executive - Non Independent Director - - - - - - - 29-09-1990 - 09-02-2019 - 1 - 0 0 - - 0

 
Annexure II
Website Affirmations
Sr. No. Item Compliance status Details of non-compliance Web address
1 Details of business Yes - www.norrispharma.com/about-us/
2 Terms and conditions of appointment of independent directors Yes - www.norrispharma.com/policies/
3 Composition of various committees of board of directors Yes - www.norrispharma.com/corporate-governance
4 Code of conduct of board of directors and senior management personnel Yes - www.norrispharma.com/code-of-conduct/
5 Details of establishment of vigil mechanism or whistle blower policy Yes - www.norrispharma.com/policies/
6 Criteria of making payments to non-executive directors Yes - www.norrispharma.com/policies/
7 Policy on dealing with related party transactions Yes - www.norrispharma.com/policies/
8 Policy for determining material subsidiaries Yes - www.norrispharma.com/policies/
9 Details of familiarization programmes imparted to independent directors Yes - www.norrispharma.com/policies/
10 Email address for grievance redressal and other relevant details Yes - www.norrispharma.com/investor-redressal/
11 Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances Yes - www.norrispharma.com/investor-redressal/
12 Financial results Yes - www.norrispharma.com/financial-results/
13 Shareholding pattern Yes - www.norrispharma.com/shareholding-pattern/
14 Details of agreements entered into with the media companies and/or their associates NA - -
16 New name and the old name of the listed entity NA - -
Disclosure of notes on website in terms of Listing Regulations explantory -

 
Annexure III
III. Affirmations
Sr Particulars Regulation Number Compliance status(Yes/No/NA) If status is “No” details of non-compliance may be given here
no record found
Any other information to be provided -

1 Name of signatory VINAY RANA
2 Designation Company Secretary and Compliance Officer
 
Annexure IV
Additional Half Yearly Disclosure
I. Disclosure of Loans/ guarantees/comfort letters /securities etc.

Applicability of disclosure -
Reason for Non Applicability -

(A)Any loan or any other form of debt advanced by the listed entity directly or indirectly to:
Entity Aggregate amount advanced during six months Balance outstanding at the end of six months
no record found

(B) Any guarantee/ comfort letter (by whatever name called) provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by:
Entity Type (guarantee, comfort letter etc.) Aggregate amount of issuance during six months Balance outstanding at the end of six months(taking into account any invocation)
no record found

(C ) Any security provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by:
Entity Type of security (cash, shares etc.) Aggregate value of security provided during six months Balance outstanding at the end of six months
no record found

(D) Additional Information
Affirmations Compliance Status
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company.
Name -
Designation -
Place -
Date

Signatory Details:
Name of signatory VINAY RANA
Designation of person Company Secretary and Compliance Officer
Place ANKLESHWAR
Date 16/05/2019

Site optimized for IE9 & above. | Disclaimer | Website Policies | Privacy Policy | Sitemap Copyright © BSE Ltd. All Rights Reserved.
13 Jul 25 | 07:55 (IST)
(94)